Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine

CompletedOBSERVATIONAL
Enrollment

809

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

July 31, 2017

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

IPV

IPV will be vaccinated at 2 months of age act as the first dose of poliovirus vaccine in the study group1 to group 4,group8 to group 11. IPV will be given at 3 month of age act as second vaccine in group 8,9,12

BIOLOGICAL

OPV

"OPV will be vaccinated at 3 and 4 months of age, act as the second and third dose of poliovirus vaccine in the study group 1 to group 4,group 10 to group 11.~OPV will be vaccinated at 2, 3 and 4 months of age act as the full three primary immunization doses of polio virus vaccine in the study group 5 to group 7."

Trial Locations (5)

Unknown

Guangdong Center for Disease Control and Prevention, Guangzhou

Hubei Center for Disease Control and Prevention, Wuhan

Jilin Center for Disease Control and Prevention, Changchun

Ningxia Center for Disease Control and Prevention, Yinchuan

Tianjin Center for Disease Control and Prevention, Tianjin

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

Tianjin Center for Disease Control and Prevention

UNKNOWN

collaborator

Jilin Center for Disease Control and Prevention

UNKNOWN

collaborator

Hubei Provincial Center for Disease Control and Prevention

OTHER

collaborator

Guangdong Center for Disease Prevention and Control

OTHER_GOV

collaborator

Ningxia Center for Disease Control and Prevention

UNKNOWN

lead

Centers for Disease Control and Prevention, China

OTHER_GOV

NCT02643446 - Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine | Biotech Hunter | Biotech Hunter